-
Mbappe injured as Zidane wins on France debut, Italy lose on Mancini return
-
Alcaraz helps Europe into Laver Cup lead
-
Senegal draw in Vieira debut, Nigeria survive scare as Cape Verde crash
-
Six missing after building collapses in historic Athens district
-
U2 performs surprise 50th anniversary gigs in Dublin
-
Mbappe scores but suffers knee injury as Zidane gets debut France win
-
Pope calls worshippers 'saints of France' after AI warning
-
Mancini's Italy return spoiled by Belgium defeat
-
US court sides with Pentagon in Anthropic AI ban
-
Rodri confident in Man City innocence despite reported charges
-
Wall Street stocks rise, greeting optimism over possible US-Iran deal
-
Jay-Z rape accuser says she made 'false accusations'
-
NFL players chief raises concerns over pitch for Maracana game
-
Senegal draw first match under Vieira and Nigeria survive scare
-
Daytime Russian attacks kill seven in Kyiv
-
Trump, Xi end summit long on pomp, but short on progress
-
Spotting AI writing: how reliable are the detectors?
-
Russia not preparing for conflict with Europe, Putin says
-
French youth await pope after AI 'paradise of machines' warning
-
Trump's photo of Xi greeting carries signs of AI
-
Man City found guilty of Premier League charges, set to appeal: reports
-
Six missing after building blast in historic Athens district
-
Embolo follows Xhaka out of Swiss squad over fake Covid documents
-
Millions in US northeast brace for powerful storm
-
Trump, Xi inspect founding documents of US democracy to close summit
-
Assefa seeks 'better than my best' at Berlin marathon
-
'Bottle Claus': Kipchoge's 'hero' helping runners chase Berlin marathon glory
-
US court refuses to overturn Pentagon ban on Anthropic
-
Olympic medallist Samba-Mayela handed provisional doping ban
-
Verstappen and Norris blame slow cars as Mercedes tops qualifying
-
First US trial against TikTok to open Monday
-
Crowds cheer pope in Paris after AI 'paradise of machines' warning
-
Palmer misses 'too many' England games, says Tuchel
-
Teen swimmer makes Games history as Thai, Chinese sprinters win gold
-
UN refugees chief warns conditions in W.Sahara 'deteriorating'
-
Man City found guilty of 114 Premier League charges - reports
-
Antonelli 'mad' about crash in Azerbaijan qualifying
-
Concerns over 'missing' UK explorer Ranulph Fiennes
-
'Perfect lap' gives Russell pole for Azerbaijan GP as Antonelli crashes out
-
Suspected Paris killer of Argentine rugby star begs forgiveness
-
UN Security Council condemns Houthi attacks on Saudi Arabia
-
Oil prices fall on cautious hopes for US-Iran progress
-
China swimmer makes Asian Games history as Thai wins 100m sprint
-
Noskova, Muchova take Czech Republic into BJK Cup final
-
Top French literary prize drops best-selling novel over AI claims
-
Thai sprinter Puripol breaks own Asian Games record to win 100m gold
-
US 'must choose' whether to end war: Iran president
-
Russell takes pole for Azerbaijan GP, Antonelli crashes out
-
Pope warns against losing humanity in AI-driven 'paradise of machines'
-
Williams boss hails Chadwick as F1 inspiration for women
First person vaccinated during trial of new Ebola jab
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.
More than 1,000 people have been killed in the DRC and Uganda since the outbreak emerged in May, according to the World Health Organization.
Researchers and health organisations have since been racing to get a vaccine or treatment for the relatively rare strain to the clinical trial stage where it is tested on humans.
Earlier this month, a team at Oxford University in the UK announced it was launching the first trial for its ChAdOx1 BDBV vaccine, which uses the same technology as AstraZeneca's Covid-19 vaccine.
The first dose was administered to a 37-year-old volunteer named Ed Hunt in Oxford on Friday, a university spokesman told AFP.
"We've taken this vaccine candidate from concept to clinic in just eight weeks," David Pulido-Gomez of Oxford's Pandemic Sciences Institute said in a statement.
"Reaching this milestone in such a short timeframe reflects an extraordinary collaborative effort," he added.
The trial received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), while the Serum Institute of India has already manufactured a stockpile of 620,000 doses.
The phase 1 trial plans to assess the safety and effectiveness of the vaccine in 50 health adults in the coming weeks. The researchers are currently recruiting more volunteers.
Given regulatory approval, the team is preparing for more clinical studies of the vaccine with partners in Uganda, Oxford said.
Several other Bundibugyo vaccine candidates are also being urgently developed towards the trial stage, while two potential treatments are being worked on.
The Ebola outbreak is the 17th in the DRC's history, but just the third caused by the Bundibugyo strain, for which there are no approved vaccines or treatments.
WHO chief Tedros Adhanom Ghebreyesus warned last week that the outbreak had over the past month "expanded faster than any previous outbreak" of Ebola.
The outbreak has remained concentrated in the vast country's mineral-rich and conflict-plagued northeastern province.
Cases of Ebola, which spreads through close contact and infected bodily fluids, have also been found in four other DRC provinces.
T.Sanchez--AT